Sanofi-Aventis earnings drop 29 per cent in 1st quarter on loss of swine flu vaccine sales
PARIS – Sanofi-Aventis SA says its earnings fell by nearly 30 per cent in the first quarter as low swine flu vaccine sales battered the French drug maker’s bottom line.

